Joel Greenblatt’s MDT Holdings & Trades

First Buy
Q1 2015
Duration Held
43 Quarters
Largest Add
Q1 2020
+254,530 Shares
Current Position
288,010 Shares
$27.43 M Value

Joel Greenblatt's MDT Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 288,010 shares of Medtronic plc (MDT) worth $27.43 M, representing 0.12% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.

Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2020, adding 254,530 shares. Largest reduction occurred in Q4 2018, reducing 312,943 shares.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's Medtronic plc (MDT) Holding Value Over Time

Track share changes against reported price movement

Quarterly Medtronic plc (MDT) Trades by Joel Greenblatt

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2015 +37,793 New Buy 37,793 $77.98
Q2 2015 -37,793 Sold Out 37,793 $0.00
Q3 2015 +10,247 New Buy 10,247 $66.95
Q4 2015 -7,542 Reduce 73.60% 2,705 $76.89
Q1 2016 -2,705 Sold Out 2,705 $0.00
Q2 2016 +167,825 New Buy 167,825 $86.77
Q3 2016 -167,825 Sold Out 167,825 $0.00
Q1 2017 +224,898 New Buy 224,898 $80.56
Q2 2017 +216,496 Add 96.26% 441,394 $88.75
Q3 2017 -124,502 Reduce 28.21% 316,892 $77.77
Q4 2017 -112,620 Reduce 35.54% 204,272 $80.75
Q1 2018 +223,685 Add 109.50% 427,957 $80.22
Q2 2018 +223,176 Add 52.15% 651,133 $85.61
Q3 2018 +12,418 Add 1.91% 663,551 $98.37
Q4 2018 -312,943 Reduce 47.16% 350,608 $90.96
Q1 2019 -52,593 Reduce 15.00% 298,015 $91.08
Q2 2019 -117,816 Reduce 39.53% 180,199 $97.39
Q3 2019 -85,617 Reduce 47.51% 94,582 $108.61
Q4 2019 -24,658 Reduce 26.07% 69,924 $113.45
Q1 2020 +254,530 Add 364.01% 324,454 $90.18
Q2 2020 +9,285 Add 2.86% 333,739 $91.70
Q3 2020 -228,942 Reduce 68.60% 104,797 $103.92
Q4 2020 -18,193 Reduce 17.36% 86,604 $117.14
Q1 2021 -24,337 Reduce 28.10% 62,267 $118.14
Q2 2021 +13,820 Add 22.19% 76,087 $124.13
Q3 2021 +11,604 Add 15.25% 87,691 $125.35
Q4 2021 +72,292 Add 82.44% 159,983 $103.45
Q1 2022 -64,778 Reduce 40.49% 95,205 $110.95
Q2 2022 +71,213 Add 74.80% 166,418 $89.75
Q3 2022 -64,084 Reduce 38.51% 102,334 $80.75
Q4 2022 -2,122 Reduce 2.07% 100,212 $77.72
Q1 2023 -991 Reduce 0.99% 99,221 $80.62
Q2 2023 -41,041 Reduce 41.36% 58,180 $88.10
Q3 2023 -38,647 Reduce 66.43% 19,533 $78.36
Q4 2023 +29,676 Add 151.93% 49,209 $82.38
Q1 2024 +134,621 Add 273.57% 183,830 $87.15
Q2 2024 +156,836 Add 85.32% 340,666 $78.71
Q3 2024 -102,829 Reduce 30.18% 237,837 $90.03
Q4 2024 -71,113 Reduce 29.90% 166,724 $79.88
Q1 2025 -20,456 Reduce 12.27% 146,268 $89.86
Q2 2025 +111,613 Add 76.31% 257,881 $87.17
Q3 2025 +30,129 Add 11.68% 288,010 $95.24

Joel Greenblatt's Medtronic plc Investment FAQs

Joel Greenblatt first purchased Medtronic plc (MDT) in Q1 2015, acquiring 37,793 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held Medtronic plc (MDT) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt's largest addition to Medtronic plc (MDT) was in Q1 2020, adding 324,454 shares worth $29.26 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 288,010 shares of Medtronic plc (MDT), valued at approximately $27.43 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Medtronic plc (MDT) represents approximately 0.12% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt's peak holding in Medtronic plc (MDT) was 663,551 shares, as reported at the end of Q3 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.